Medison Pharma

From Wikitia
Jump to navigation Jump to search
Medison Pharma Group
Private company
IndustryPharmaceutical
Founded1996; 26 years ago (1996)
FounderMeir Jakobsohn
Headquarters
Petah Tikva
,
Israel
Key people
Meir Jakobsohn
ProductsPharmaceuticals
Websitewww.medison.co.il

Medison Pharma Group (“Medison”) is a pharmaceutical company[1] that specializes in the multi-regional commercialization of highly innovative therapies[2] developed and manufactured by biotechnology companies, primarily in the fields of oncology,[3] hematology,[4] neurology[5] and rare diseases.[6] As a global partner for multinational biotechnology companies, Medison’s partners include pharma heavyweights, such as: Amgen,[7] Biogen, Vertex Pharmaceuticals,[8] Ipsen,[9] Array Biopharma,[10] BioMarin Pharmaceutical, Alnylam Pharmaceuticals,[11] and BeiGene.[12]

The company was founded in 1996 in Israel by Meir Jakobsohn, who has been serving as CEO since its inception. In Israel, Medison solidified its position to become one of the top specialty pharma companies in Israel[13] and in 2020 became one of the top three pharma companies in Israel.[14]

Medison operates through three arms that each manage a different territorial area: Medison Israel,[15] which is the largest pharma partner in Israel for delivering innovative therapies,[16] Medison Canada[17] and Medison CEE[18] in Central Eastern Europe. The group's headquarters is in Petah Tikva, Israel, with regional offices in Toronto and Bucharest.

Medison has an in-house research body that evaluates and examines technologies and developments in all areas of the company's expertise.[19] It also has an investment arm called Medison Ventures,[20] which acts as an active investor in life science projects around drug development and digital health, including through a partnership in an eHealth venture technology incubator.[21]

References

  1. "Medison Pharma Ltd". Dun & Bradstreet. Retrieved 29 December 2020.
  2. "Medison Pharma Enters Exclusive Distribution Agreement with Deciphera Pharmaceuticals to Commercialize QINLOCK® (Ripretinib) in a Multi-Regional Agreement". Newswire. 6 November 2020. Retrieved 29 December 2020.
  3. "IDM and Medison Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in Israel". Sofinnova Partners. 14 March 2006. Retrieved 29 December 2020.
  4. "Rigel and Medison Announce Health Canada Approval of TAVALISSE®, an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia". Cision. 23 November 2020. Retrieved 29 December 2020.
  5. "Biohaven Enters Into Partnership With Medison Pharma To Distribute NURTEC™ ODT In Israel". Cision. 16 April 2020. Retrieved 29 December 2020.
  6. Abramson, Edna (2 March 2014). "The Israeli company that provides drugs for rare diseases". Ynet. Retrieved 29 December 2020.
  7. "Amgen Builds its Digital Health Capabilities Through Investment in Leading Digital Health Incubator". Digital Health News. 25 October 2016. Retrieved 29 December 2020.
  8. "Vertex Announces European Commission Approval For ORKAMBI (Lumacaftor/Ivacaftor)". Pharma Journalist. 22 January 2019. Retrieved 29 December 2020.
  9. "PharmAthene Signs Agreement With Medison Pharma To Distribute Biodefense Products In Israel". Pharmaceutical Online. 20 November 2008. Retrieved 29 December 2020.
  10. "Binimetinib - Array BioPharma/Ono Pharmaceutical/Pierre Fabre". AdisInsight Drugs.
  11. "Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize RNAi Therapeutics in Israel". Business Wire. 21 January 2019. Retrieved 29 December 2020.
  12. "BeiGene and Medison Pharma Announce Exclusive Distribution Agreement and Acceptance of New Drug Application for BTK Inhibitor BRUKINSA™ (zanubrutinib) in Israel". GlobeNewswire. 21 May 2020. Retrieved 29 December 2020.
  13. Weinreb, Gali (5 November 2006). "Marketing company "Madison Pharma" has acquired the marketing group "Pharmatop-Pharmatrade"". Globes. Retrieved 29 December 2020.
  14. "Gender diversity? It's so 2019. In honor of Women's Day we have found the companies where the equal presence of women is part of the agenda". Mako, Keshet Media Group. 8 March 2020. Retrieved 29 December 2020.
  15. "Tris Pharma and Medison Pharma Announce Exclusive License Agreement to Commercialize Tris' Quillivant XR in Israel". Tris Pharma. Retrieved 29 December 2020.
  16. "Collaborations with drug companies that provide drug treatment to MS patients". The Israel Multiple Sclerosis Society. Retrieved 29 December 2020.
  17. "Medison Establishes Canada's Only Innovative Pharma Commercial Company". Financial Post. 25 June 2019. Retrieved 29 December 2020.
  18. "Medison Pharma and Alpha Tau Medical Announce a Collaboration in the Oncology Field in Central and Eastern Europe". News Wire. 15 June 2020. Retrieved 29 December 2020.
  19. "Bringing Access to the Table". Medison Ventures. Retrieved 29 December 2020.
  20. "Medison Ventures". Retrieved 29 December 2020.
  21. "Medison Pharma and Alpha Tau Medical Announce a Collaboration in the Oncology Field in Central and Eastern Europe". News Wire. 15 June 2020. Retrieved 29 December 2020.

External links

Add External links

This article "Medison Pharma" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.